Please complete the CAPTCHA to continue
@sellaslife.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Francomano is listed as Chief Commercial Officer | Revenue Growth | Global Commercialization | Market Access | Inspirational Leadership | Financial Acumen | Top Performer Driving Shareholder Value at SynOx Therapeutics, based in West Chester, Pennsylvania, United States. AeroLeads shows a work email signal at sellaslife.com and a matched LinkedIn profile for Robert Francomano.
Robert Francomano previously worked as Chief Commercial Officer (CCO) at Synox Therapeutics and Chief Commercial Officer (CCO) at Sellas Life Sciences Group, Inc.. Robert Francomano holds Management Executive Education, Computer Science & Artificial Intelligence Laboratory from Massachusetts Institute Of Technology.
This section adds company-level context without repeating Robert Francomano's masked contact details.
AeroLeads found 1 current-domain work email signal for Robert Francomano. Compare company email patterns before reaching out.
Robert Francomano is a tenured and distinguished Chief Commercial Officer with extensive experience in elevating oncology clinical-stage organizations to global commercial prominence. His expertise is underpinned by a compelling track record of exceeding financial goals through the deployment of sophisticated commercialization strategies. In recent roles, Robert achieved the number one ranked impact on stock price growth percentage for biotech organizations executing their first commercial product launch. Throughout Robert’s illustrious career, he has proven an innate ability to propel his organizations forward. As Chief Commercial Officer of both SELLAS Life Sciences and Stemline Therapeutics, he was the architect of building and integrating a commercial operations to support and/or drive revenue generation. His strategic leadership at Stemline Therapeutics culminated in surpassing Wall Street’s first full-year revenue projections by 175% following the successful U.S. launch and commercialization of their premier product. This achievement not only reflects his adeptness in strategic planning and execution but also his capacity to significantly influence market perceptions and investor confidence.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Dublin City, County Dublin, IE
As the Chief Commercial Officer at SynOx Therapeutics Limited, a pioneering late-stage clinical biopharmaceutical company, my role is to architect and drive the strategic transformation of SynOx into a global commercial enterprise. I am primarily focused on spearheading the CSF1(R) inhibiting monoclonal antibody emactuzumab’s global commercialization.
New York, NY, US
Growth-focused executive charged with building a comprehensive commercial infrastructure & capability from concept to commercialization. Served as the key catalyst for the corporate transition from clinical stage to that of a revenue generating entity. By strategically orchestrating business planning initiatives, successfully developed the groundwork for.
New York, New York, US
Led the transformation of Stemline from a clinical-stage entity to one with a full commercial & Medical capability and infrastructure. Established from the ground floor up high-performing Marketing, Diagnostics, Sales, Access & Reimbursement, Operations and Medical Affairs functions for U.S. & global markets.As demonstrated by Bloomberg data analysis.
Illinois, US
Headed up the development and execution of the go-to-market strategy for the global launch of pacritinib in myelofibrosis. Developed the asset’s life cycle strategy to expand labeled indications to both solid and hematologic malignancies via a multifactorial analytics process. Served as Chair for the Joint Commercialization Committee (JCC).
Delivered strategic counsel to VP and C-Suite Executives regarding oncology and rare disease areas for Top 10 pharmaceutical and biotechnology organizations. Adeptly redirected strategic focus related to seemingly insurmountable challenges, leading to greater corporate effectiveness.
New York, New York, US
Prepared and delivered launch readiness in 66 global markets while producing successful on-time, first-in-class product launches. Developed and led the execution of short and long-term global marketing strategy for assets treating Mantle Cell Lymphoma and Renal Cell Carcinoma.
Brentford, Middlesex, GB
Oversaw commercial aspect of eight extensive clinical development programs inclusive of IND-enabling, phase II & III trials. Developed the global commercial strategy for emerging oncology assets from candidate selection through phase 3.
Quick answers generated from the profile data available on this page.
Robert Francomano works for SynOx Therapeutics.
Robert Francomano is listed as Chief Commercial Officer | Revenue Growth | Global Commercialization | Market Access | Inspirational Leadership | Financial Acumen | Top Performer Driving Shareholder Value at SynOx Therapeutics.
AeroLeads has found 1 work email signal at @sellaslife.com for Robert Francomano at SynOx Therapeutics.
Robert Francomano is based in West Chester, Pennsylvania, United States while working with SynOx Therapeutics.
Robert Francomano has worked for Synox Therapeutics, Sellas Life Sciences Group, Inc., Stemline, Baxalta, and Senior Vice President, Oncology.
You can use AeroLeads to view verified contact signals for Robert Francomano at SynOx Therapeutics, including work email, phone, and LinkedIn data when available.
Robert Francomano holds Management Executive Education, Computer Science & Artificial Intelligence Laboratory from Massachusetts Institute Of Technology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts